ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

39,176Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 2456

$1.96M Total Retail Price of All Prescriptions

Rank: 6 out of 2456

982 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 982 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 982 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 38,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
CRESTOR 1,718 1,674 10 1 25
OMEPRAZOLE 1,624 1,602 2 3
AMLODIPINE BESYLATE 1,600 1,578 3 5
ATENOLOL 1,438 1,391 4 6
ATORVASTATIN CALCIUM 1,302 1,284 5 12
METOPROLOL SUCCINATE 1,271 1,248 6 13
LEVOTHYROXINE SODIUM 1,244 1,231 7 4
LISINOPRIL 1,186 1,166 8 1
SIMVASTATIN 992 958 9 2
WARFARIN SODIUM 973 971 10 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 940 904 10 11 41
CARVEDILOL 785 746 12 54
TORSEMIDE 721 720 10 13 146
ISOSORBIDE MONONITRATE ER 710 710 14 48
ALENDRONATE SODIUM 685 683 15 19
METFORMIN HCL 684 638 16 11
ZOLPIDEM TARTRATE 583 575 17 28
FUROSEMIDE 523 519 18 8
DIOVAN 499 499 19 26
LIPITOR 439 435 20 63
LOSARTAN POTASSIUM 433 421 21 18
SPIRONOLACTONE-HCTZ 425 395 10 22 195
NEXIUM 415 411 23 80
GABAPENTIN 396 385 24 16
PANTOPRAZOLE SODIUM 371 371 25 37
ALLOPURINOL 371 359 25 27
NIFEDIPINE ER 362 361 27 61
GLIMEPIRIDE 360 354 28 74
PRAVASTATIN SODIUM 358 354 29 15
LOSARTAN-HYDROCHLOROTHIAZIDE 351 347 30 117
SERTRALINE HCL 342 341 31 21
DIOVAN HCT 339 328 32 139
LIDODERM 319 318 33 58
METOPROLOL TARTRATE 314 314 34 10
HYDROCHLOROTHIAZIDE 303 303 35 7
MIRTAZAPINE 292 292 36 29
CITALOPRAM HBR 271 271 37 14
FAMOTIDINE 266 247 38 84
DOXAZOSIN MESYLATE 258 258 39 71
POTASSIUM CHLORIDE 255 241 40 33
DONEPEZIL HCL 235 235 41 23
TAMSULOSIN HCL 231 231 42 32
CLOPIDOGREL 230 227 43 55
PROAIR HFA 229 224 44 22
SOLARAZE 228 224 45 264
NAMENDA 228 228 45 42
SPIRONOLACTONE 197 197 47 73
PLAVIX 195 191 48 79
DIGOXIN 186 186 49 49
NITROSTAT 185 185 50 169
FLUTICASONE PROPIONATE 180 180 51 30
POLYETHYLENE GLYCOL 3350 175 175 52 64
TRICOR 171 152 53 163
PAROXETINE HCL 167 167 54 56
JANUVIA 161 154 55 81
VENLAFAXINE HCL ER 160 153 56 92
METFORMIN HCL ER 159 149 57 59
TRAMADOL HCL 156 155 58 24
NAPROXEN 148 141 59 109
EXELON 145 145 60 161
MECLIZINE HCL 141 134 61 107
ADVAIR DISKUS 139 137 62 36
QUETIAPINE FUMARATE 136 136 63 47
IBUPROFEN 124 123 64 52
TRAZODONE HCL 123 123 65 17
KETOCONAZOLE 119 119 66 221
NITROGLYCERIN PATCH 118 118 67 134
FINASTERIDE 116 116 68 66
TRAMADOL HCL-ACETAMINOPHEN 116 111 68 345
HYDRALAZINE HCL 112 112 70 105
CLOTRIMAZOLE-BETAMETHASONE 108 91 71 182
TRIAMCINOLONE ACETONIDE 106 105 72 131
LOVASTATIN 104 104 73 34
ENALAPRIL MALEATE 101 101 74 70
RANITIDINE HCL 100 93 75 31
VOLTAREN 97 96 76 241
AMLODIPINE BESYLATE-BENAZEPRIL 96 96 77 144
FENOFIBRATE 95 77 78 68
ZETIA 94 91 79 86
IPRATROPIUM BROMIDE 93 93 80 273
ALCOHOL SWABS 91 86 81 222
LABETALOL HCL 91 91 81 128
CYMBALTA 86 86 83 65
CIPROFLOXACIN HCL 84 82 84 87
CARBIDOPA-LEVODOPA 84 84 84 82
OXYBUTYNIN CHLORIDE ER 83 83 86 94
VESICARE 79 79 87 205
GLIPIZIDE XL 77 68 88 168
LACTULOSE 76 76 89 88
LOVAZA 76 72 89 219
SPIRIVA 73 73 91 43
CEFUROXIME 72 72 92 244
LEVOXYL 71 71 93 97
PROCTOZONE-HC 71 67 93 341
GLYBURIDE 69 69 R 95 40
BUSPIRONE HCL 69 69 95 157
ZOVIRAX 68 59 97 382
AMIODARONE HCL 68 68 97 203
TERAZOSIN HCL 67 67 99 76
LYRICA 67 67 99 199
PROPRANOLOL HCL 66 66 101 108
CREON 66 65 101 251
CLOBETASOL PROPIONATE 63 63 103 208
MICARDIS 61 61 104 291
DILTIAZEM 24HR CD 61 61 104 113
TRIAMTERENE-HCTZ 61 61 104 53
AMMONIUM LACTATE 59 59 107 265
FLUOXETINE HCL 59 59 107 45
IBANDRONATE SODIUM 58 57 109 341
AZITHROMYCIN 57 56 110 60
LIDOCAINE 57 57 110 284
ESCITALOPRAM OXALATE 56 56 112 116
BETAMETHASONE DIPROPIONATE 55 55 113 233
ACETAMINOPHEN-CODEINE 52 52 S3 114 106
VENLAFAXINE HCL 51 51 115 188
ACTOS 51 47 115 124
PROCHLORPERAZINE MALEATE 50 50 117 279
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.